vimarsana.com
Home
Live Updates
Chemoimmunotherapy dramatically improved survival of high-ri
Chemoimmunotherapy dramatically improved survival of high-ri
Chemoimmunotherapy dramatically improved survival of high-risk neuroblastoma patients
Wayne Furman, MD, of the Department of Oncology Solid Tumor Division, is the first and corresponding author of the paper pubished in the Journal of
Related Keywords
University Of Southern California ,
California ,
United States ,
Taiwan ,
San Diego ,
Memorial Hospital ,
Massachusetts ,
Elizabeth Stewart ,
Jacquelyn Hank ,
Andrew Davidoff ,
Michael Bishop ,
Wayne Furman ,
Sara Federico ,
Los Angeles ,
Chia Wei Hsu ,
Rachel Brennan ,
Alice Yu ,
Matthew Krasin ,
Paul Sondel ,
Linkou Chang Gung ,
Beth Mccarville ,
Alberto Pappo ,
Stephen Gillies ,
Brandon Triplett ,
Barry Shulkin ,
Victor Santana ,
Sara Helmig ,
Haitao Pan ,
Jianrong Wu ,
University Of California ,
University Of Hong Kong ,
Merck Kga ,
Translational Cancer Research ,
Jude Children Research Hospital ,
Drug Administration ,
Cure Childhood Cancer Foundation ,
Department Of Oncology Solid Tumor Division ,
Chang Gung University ,
Institute Of Stem Cell ,
University Of Wisconsin ,
Merck Kgaa ,
Serono ,
Department Of Oncology ,
University Of Kentucky ,
Oncology Solid Tumor Division ,
Jude Children ,
Research Hospital ,
German Based Merck ,
Teresa Santiago ,
Fariba Navid ,
Hospital Los Angeles ,
Southern California ,
Provenance Biopharmaceuticals ,
Stem Cell ,
Linkou Chang Gung Memorial Hospital ,
Wing Leung ,
Kid Cancer ,
Clinical Oncology ,
Newly Diagnosed High Risk Neuroblastoma ,
Updated Results ,